Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis

Nature Communications

Volumn 2, Issue 1, 2011, Pages

  Li, Shaowei ^a   Thangapazham, Rajesh L ^a   Wang, Ji An ^a   Rajesh, Sangeetha ^a   Kao, Tzu Cheg ^a   Sperling, Leonard ^a   Moss, Joel ^b   Darling, Thomas N ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; DNA; MTORC1 COMPLEX, HUMAN; PROTEIN; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE MUTATION; HAIR FOLLICLE; HAMARTOMA; HUMAN; HUMAN CELL; KERATINOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; NULL CELL; SKIN TUMOR; TUBEROUS SCLEROSIS; ANIMAL; BIOPSY; DNA SEQUENCE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; XENOGRAFT;

MAMMALIA;

ANIMALS; BIOPSY; DNA; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HAIR FOLLICLE; HAMARTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PROTEINS; SEQUENCE ANALYSIS, DNA; SIROLIMUS; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 79952461100     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1236     Document Type: Article

References (48)

1. Albrecht, E. Uber hamartome. Verh. Dtsch. Ges. Pathol. 7, 153-157 (1904).
2. Darling, T. N. Hitting the mark in hamartoma syndromes. Adv. Dermatol. 22, 181-200 (2006). (Pubitemid 44960614)
3. Curatolo, P., Bombardieri, R. & Jozwiak, S. Tuberous sclerosis. Lancet 372, 657-668 (2008).
4. Butterworth, T. & Wilson, M. Dermatologic aspects of tuberous sclerosis. Arch. Dermatol. Syphilol. 43, 1-41 (1941).
5. Nickel, W. R. & Reed, W. B. Tuberous sclerosis. Special reference to the microscopic alterations in the cutaneous hamartomas. Arch. Dermatol. 85, 209-226 (1962).
6. Reed, R. J. & Ackerman, A. B. Pathology of the adventitial dermis. Anatomic observations and biologic speculations. Hum. Pathol. 4, 207-217 (1973).
7. Ackerman, A., Reddy, V. & Soyer, H. Fibrous papule. in Neoplasms with Follicular Diferentiation (eds Ackerman, A., Reddy, V. & Soyer, H.) 175-190 (Ardor Scribendi, 2001).
8. Misago, N., Kimura, T. & Narisawa, Y. Fibrofolliculoma/trichodiscoma and fbrous papule (perifollicular fbroma/angiofbroma): a revaluation of the histopathological and immunohistochemical features. J. Cutan. Pathol. 36, 943-951 (2009).
9. Millar, S. E. Molecular mechanisms regulating hair follicle development. J. Invest Dermatol. 118, 216-225 (2002). (Pubitemid 34158473)
10. Weinberg, W. C et al Reconstitution of hair follicle development in vivo: determination of follicle formation, hair growth, and hair quality by dermal cells. J. Invest Dermatol. 100, 229-236 (1993). (Pubitemid 23083161)
11. Jahoda, C A., Reynolds, A. J. & Oliver, R. F. Induction of hair growth in ear wounds by cultured dermal papilla cells. J. Invest Dermatol. 101, 584-590 (1993). (Pubitemid 23285857)
12. Ehama, R. et al Hair follicle regeneration using grafed rodent and human cells. J. Invest Dermatol. 127, 2106-2115 (2007). (Pubitemid 47258478)
13. Yang, C C & Cotsarelis, G. Review of hair follicle dermal cells. J. Dermatol. Sci. 57, 2-11 (2010).
14. Kwiatkowski, D. J. & Manning, B. D. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14, R251-R258 (2005). (Pubitemid 41631882)
15. Niida, Y. et al Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests diferent genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet 69, 493-503 (2001). (Pubitemid 32777689)
16. Karbowniczek, M., Yu, J. & Henske, E. P. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures. Am. J. Pathol. 162, 491-500 (2003). (Pubitemid 36267856)
17. Crino, P. B., Aronica, E., Baltuch, G. & Nathanson, K. L. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 74, 1716-1723 (2010).
18. Wienecke, R. et al. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am. J. Kidney Dis. 48, e27-e29 (2006). (Pubitemid 44262422)
19. Franz, D. N. et al Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann. Neurol. 59, 490-498 (2006). (Pubitemid 43358069)
20. Bissler, J. J. et al Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358, 140-151 (2008).
21. Hofauer, G. F. et al Te mTOR inhibitor rapamycin signifcantly improves facial angiofbroma lesions in a patient with tuberous sclerosis. Br. J. Dermatol. 159, 473-475 (2008).
22. Koenig, M. K., Butler, I. J. & Northrup, H. Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex. J. Child Neurol. 23, 1238-1239 (2008).
23. Haidinger, M. et al Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical efectiveness and implications for innate immunity Transpl. Int 23, 777-785 (2010).
24. Haemel, A. K., O'Brian, A. L. & Teng, J. M. Topical rapamycin: a novel approach to facial angiofbromas in tuberous sclerosis. Arch. Dermatol. 146, 715-718 (2010).
25. Krueger, D. A. et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 363, 1801-1811 (2010).
26. Li, S. et al Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. Proc. Natl Acad. Sci. USA 105, 3539-3544 (2008). (Pubitemid 351723588)
27. Metcalfe, A. D. & Ferguson, M. W. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J. R. Soc. Interface 4, 413-437 (2007).
28. Aschraf, A. et al MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J. Neurosci. 28, 12581-12590 (2008).
29. Meyer, K. C. et al Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br. J. Dermatol. 159, 1077-1085 (2008).
30. Soma, T., Tajima, M. & Kishimoto, J. Hair cycle-specifc expression of versican in human hair follicles. J. Dermatol. Sci. 39, 147-154 (2005). (Pubitemid 41225379)
31. Sellheyer, K. & Krahl, D. Spatiotemporal expression pattern of neuroepithelial stem cell marker nestin suggests a role in dermal homeostasis, neovasculogenesis, and tumor stroma development: a study on embryonic and adult human skin. J. Am. Acad. Dermatol. 63, 93-113 (2010).
32. Cotsarelis, G. Epithelial stem cells: a folliculocentric view. J. Invest. Dermatol. 126, 1459-1468 (2006).
33. Sperling, L. C., Hussey, S., Sorrells, T., Wang, J. A. & Darling, T. Cytokeratin 75 expression in central, centrifugal, cicatricial alopecia\new observations in normal and diseased hair follicles. J. Cutan Pathol. 37, 243-248 (2010).
34. Chuong, C. M., Cotsarelis, G. & Stenn, K. Defning hair follicles in the age of stem cell bioengineering. J. Invest. Dermatol. 127, 2098-2100 (2007). (Pubitemid 47258502)
35. Rendl, M., Lewis, L. & Fuchs, E. Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol. 3, e331 (2005).
36. Driskell, R. R., Giangreco, A., Jensen, K. B., Mulder, K. W. & Watt, F. M. Sox2-positive dermal papilla cells specify hair follicle type in mammalian epidermis. Development 136, 2815-2823 (2009).
37. Li, S. et al MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J. Exp. Med. 202, 617-624 (2005). (Pubitemid 41248413)
38. Moolten, S. E. Hamartial nature of the tuberous sclerosis complex and its bearing on the tumor problem. Arch. Intern. Med. 69, 589-623 (1942).
39. Osada, A., Iwabuchi, T., Kishimoto, J., Hamazaki, T. S. & Okochi, H. Long-term culture of mouse vibrissal dermal papilla cells and de novo hair follicle induction. Tissue Eng 13, 975-982 (2007). (Pubitemid 46870422)
40. Way S. W. et al Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum. Mol. Genet 18, 1252-1265 (2009).
41. Gan, B. et al mTORC1-dependent and-independent regulation of stem cell renewal, diferentiation, and mobilization. Proc. Natl Acad. Sci. USA 105, 19384-19389 (2008).
42. Roach, E. S., Gomez, M. R. & Northrup, H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J. Child Neurol. 13, 624-628 (1998). (Pubitemid 29035481)
43. Kato, M. et al. Expression of glial fbrillary acidic protein (GFAP) by cultured angiofbroma stroma cells from patients with tuberous sclerosis. Neuropathol. Appl. Neurobiol. 18, 559-565 (1992). (Pubitemid 23010158)
44. Pfutzner, W. et al. Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo. Proc. Natl Acad. Sci. USA 99, 13096-13101 (2002).
45. Garlick, J. A. & Taichman, L. B. Fate of human keratinocytes during reepithelialization in an organotypic culture model. Lab. Invest. 70, 916-924 (1994). (Pubitemid 24209493)
46. Granville, C. A. et al Identifcation of a highly efective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors. Clin. Cancer Res. 13, 2281-2289 (2007). (Pubitemid 46649898)
47. Perera, S. A. et al HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy. Proc. Natl Acad. Sci. USA 106, 474-479 (2009).
48. Crooks, D. M. et al Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 101, 17462-17467 (2004). (Pubitemid 39657427)